Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-11
2005-10-11
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S350000, C544S295000, C544S360000, C544S391000, C544S392000, C544S394000, C544S363000, C544S372000, C544S376000, C544S377000, C544S048000, C544S346000, C540S575000, C546S217000, C546S236000, C548S453000, C206S568000, C206S570000, C435S007200, C435S007210, C436S504000, C514S218000, C514S224200, C514S250000, C514S252140, C514S253120, C514S255030, C514S253060, C514S254080, C514S254110, C514S317000, C514S327000, C514S412000
Reexamination Certificate
active
06953801
ABSTRACT:
Melanin concentrating hormone receptor ligands (especially 1-benzyl-4-aryl-piperazines, 1-benzyl-4-aryl-piperidines and related compounds), capable of modulating MCH receptor activity, are provided. Such ligands may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting MCH receptors (e.g., receptor localization studies).
REFERENCES:
patent: 3845058 (1974-10-01), Lembo et al.
patent: 4139621 (1979-02-01), Gardner et al.
patent: 4370329 (1983-01-01), Scherm et al.
patent: 4370330 (1983-01-01), Scherm et al.
patent: 4532240 (1985-07-01), Werbel et al.
patent: 4806536 (1989-02-01), Cross et al.
patent: 4868194 (1989-09-01), Carr et al.
patent: 4921863 (1990-05-01), Sugimoto et al.
patent: 4937246 (1990-06-01), Sugihara et al.
patent: 5179095 (1993-01-01), Oinuma et al.
patent: 5569659 (1996-10-01), Reitz
patent: 5681954 (1997-10-01), Yamamoto et al.
patent: 5688798 (1997-11-01), Godel et al.
patent: 5753659 (1998-05-01), Mills
patent: 5859246 (1999-01-01), Thurkauf et al.
patent: 5869488 (1999-02-01), Shue et al.
patent: 6048876 (2000-04-01), Annoura et al.
patent: 6057371 (2000-05-01), Glennon
patent: 6127381 (2000-10-01), Basu et al.
patent: 6172229 (2001-01-01), Thurkauf et al.
patent: 6284761 (2001-09-01), Zhang et al.
patent: 6414149 (2002-07-01), Chu-Moyer et al.
patent: 6455528 (2002-09-01), Adachi et al.
patent: 2001/0039286 (2001-11-01), Dinnell et al.
patent: 2001/0049367 (2001-12-01), Bennani et al.
patent: 620234 (1963-01-01), None
patent: 177392 (1985-09-01), None
patent: 0211346 (1987-02-01), None
patent: 390654 (1994-11-01), None
patent: 0675118 (1995-10-01), None
patent: 755923 (1997-01-01), None
patent: 624584 (1998-08-01), None
patent: 1029851 (2000-08-01), None
patent: 1123928 (2001-08-01), None
patent: 549465 (1986-03-01), None
patent: 1378964 (1975-01-01), None
patent: 2001-226269 (2001-08-01), None
patent: 2002-322163 (2002-11-01), None
patent: WO 93/16057 (1993-08-01), None
patent: WO 95/34540 (1995-12-01), None
patent: WO 97/17961 (1997-05-01), None
patent: WO 97/41108 (1997-11-01), None
patent: WO 97/44334 (1997-11-01), None
patent: WO 98/04528 (1998-02-01), None
patent: WO 98/11068 (1998-03-01), None
patent: WO 99/19301 (1999-04-01), None
patent: WO 99/54305 (1999-10-01), None
patent: WO 99/54320 (1999-10-01), None
patent: WO 00/23428 (2000-04-01), None
patent: WO 00/32582 (2000-06-01), None
patent: WO 00/51984 (2000-09-01), None
patent: WO 00/55139 (2000-09-01), None
patent: WO 00/68202 (2000-11-01), None
patent: WO 01/17965 (2001-03-01), None
patent: WO 01/21169 (2001-03-01), None
patent: WO 01/21577 (2001-03-01), None
patent: WO 01/82925 (2001-11-01), None
patent: WO 01/87834 (2001-11-01), None
patent: WO 02/02744 (2002-01-01), None
patent: WO 02/04433 (2002-01-01), None
patent: WO 02/06245 (2002-01-01), None
Carpenter et al. Expert Opinion in Therapeutic Patents, vol. 12(11)p. 1639-1646 (2002).
Bednarek et al. Journal of Biological Chemistry, vol. 277, p. 13821-13826 (2002).
Hanano et al (2000) Bioorganic & Medicinal Chemistry Letters 10:881-84.
Boissier et al., “Synthesis and Pharmacological Study of New Piperazine Derivatives. I. Benzylpiperazines,” J. Med. Chem. 6(5):541-544 (1963).
Caldwell Timothy M.
Doller Dario
Gustavson Linda M.
Hutchison Alan
Peterson John M.
Fidel Seth
Kadlecek Ann
Neurogen Corporation
LandOfFree
Melanin concentrating hormone receptor ligands: substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanin concentrating hormone receptor ligands: substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanin concentrating hormone receptor ligands: substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464590